# PDEs for Triethylamine and for Methylisobutylketone - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/pdes-for-triethylamine-and-for-methylisobutylketone/c3d4c7db-7f2f-4f5c-a410-e930c81766c9

> FDA guidance document: PDEs for Triethylamine and for Methylisobutylketone. Issue date: July 25, 2017. Get complete insights and analysis.

---

## Details

- Title: PDEs for Triethylamine and for Methylisobutylketone
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2017-07-25
- Last Changed: 2020-05-15

## Related Documents

- [Antiviral Product Development--Conducting and Submitting Virology Studies to the Agency: Guidance for Submitting HBV Resistance Data](https://www.globalkeysolutions.net/guidances/guidance-document/antiviral-product-development-conducting-and-submitting-virology-studies-to-the-agency-guidance-for-submitting-hbv-resistance-data/937abe21-af65-46ce-83a8-963a0fb30d4f)
- [Antiviral Product Development--Conducting and Submitting Virology Studies to the Agency:  Guidance for Submitting HCV Resistance Data](https://www.globalkeysolutions.net/guidances/guidance-document/antiviral-product-development-conducting-and-submitting-virology-studies-to-the-agency-guidance-for-submitting-hcv-resistance-data/3b53e257-72e5-402a-9e6e-a5abd8c1a7a8)
- [Antiviral Product Development--Conducting and Submitting Virology Studies to the Agency : Guidance for Submitting Influenza Resistance Data](https://www.globalkeysolutions.net/guidances/guidance-document/antiviral-product-development-conducting-and-submitting-virology-studies-to-the-agency-guidance-for-submitting-influenza-resistance-data/88713cca-c233-4559-9c7c-6699ccbcfc65)